In accordance with the National Health and Medical Research Council (NHMRC) guidelines, Bellberry Limited is committed to upholding the highest standards of ethical conduct and transparency in research.
One key requirement is the publication of a list of studies where a waiver of consent has been granted. This ensures accountability and provides the public with visibility into research activities conducted without direct participant consent, as allowed under specific ethical conditions. The waiver of consent process applies to research where obtaining individual consent is impracticable, and the research aligns with NHMRC principles, including respect for individuals, beneficence, and justice.
| HREC ID | Study Title |
| 2018-11-1008 | Carolyn Trial/ENG 9: A Phase I/IIa Study of EGFR-Targeted EDVTMs Carrying the Cytotoxic Drug PNU-159682 (E-EDV-D682) with Concurrent Immunomodulatory Adjuvant Non-Targeted EDVs carrying α-galactosyl ceramide (EDV-GC) in (i) Cohort 1, Subjects with Advanced Pancreatic Cancer and (ii) Cohort 2, Subjects with other EGFR Expressing Solid Tumours, who have Failed First or Second-line Therapy or where other Standard Therapies are not Appropriate |
| 2019-12-1141 | The Effect of Tirzepatide versus Dulaglutide on Major Adverse Cardiovascular Events in Patients with Type 2 Diabetes (SURPASS-CVOT) |
| 2020-06-533 | Automated methods for evaluating cardiac computed tomography angiography |
| 2021-03-259 | OPT-CLI-023 Optimus CTB Non-Inferiority Analysis Protocol. |
| 2023-04-449 | AA-001: Evaluation of an artificial intelligence system for opportunistic detection of osteoporosis on chest radiographs |
| 2023-07-881 | OPT-CLI-054 – Performance validation program for a computed tomography of the chest artificial intelligence module (Annalise CTC module) |
| 2023-08-970 | Clinical Validation of Australian Human Papillomavirus Assay Project |
| 2023-08-984 | OPT-CLI-007: A retrospective, non-inferiority data analysis comparing standalone CXR AI module and unaided radiologist detection accuracy for chest x-ray findings in a non-clinical setting. |
| 2023-09-1139 | Analysing the Crohn’s Colitis Care De-Identified Clinical Quality Registry Data Registry: Improving Care and Finding Cure for Inflammatory Bowel Disease |
| 2023-10-1254 | OPT-CLI-121 A retrospective, standalone model performance evaluation of CXR AI module detection accuracy for suspected tuberculosis |
| 2023-10-1269 | ACCELERATE: PerformAnCe and outComes of tEchnoLogical advancEments in RadiAtion medicine: mulTi-cohort retrospective Evaluation |
| 2023-11-1356 | Meijer and Reference Validation Evaluation Project |
| 2023-12-1550 | Characteristics and treatment patterns of heart failure patients in Australia: CHEERS study |
| 2023-12-1555 | AVE-CSS-2023-0721 Analysis of the use of avelumab for the treatment of metastatic Merkel cell carcinoma (MCC) and urothelial carcinoma (UC) in Australia. |
| 2024-06-766 | Evaluating novel biomarkers for the diagnosis of IPF |
| 2024-09-1157 | Retrospective Clinical Evaluation of Dose Review as decision support for offline Adaptive Radiotherapy |
| 2024-09-1162 | A Randomized, Double-blind, Placebo-Controlled, Multicenter Study to Evaluate the Safety, Tolerability, and Efficacy of CB03-154 as Adjunctive Therapy in Focal Epilepsy |
| 2024-10-1432 | OligoPCa: Retrospective analysis of outcomes following stereotactic body radiation therapy for oligometastatic prostate cancer |
| 2025-03-304 | Validation of Blood-Based microRNA Signatures for Breast and Ovarian Cancer |
| 2025-03-377 | Validation of MetaPanel, a Metagenomics-based Gastrointestinal Infectious Disease Assay |
| 2025-03-409 | Study comparing pathologists HER2 scoring of breast IHC slides when supported by the Ibex Breast HER2 AI-powered solution versus the standard of care |
| 2025-04-571 | Inner West Neurology Neurophysiology Database |
| 2025-05-767 | An Outcome Evaluation of the NSW Justice Advocacy Services Diversion Program |
| 2025-07-1122 | Analysis of MetaPanel In-Market Data |
| 2025-08-1286 | 23084: Treatment patterns and characteristics of patients receiving Androgen Receptor Pathway inhibitors in a real-world setting in Australia: A retrospective prescriptions data study (TARA) |
| 2025-09-1426 | SDBioHPV01: Clinical Evaluation of STANDARD M10 hr-HPV assay |
Last updated 01/12/25